Clinical significance of mismatch repair genes immunohistochemical expression of complex endometrial hyperplasia
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective Women with Lynch syndrome have an increased risk of developing colorectal and gynecologic malignancies such as endometrial cancer. Complex hyperplasia has about a 30% risk of developing into endometrial cancer. The aim of this study was to determine the genetic risk for developing endometrial cancer by immunohistochemical staining of premalignant lesions for mutL homolog 1, mutS homolog 2, mutS homolog 6, and postmeiotic segregation increased 2. Methods Twenty cases (n=20) were selected from among patients with available sample blocks for analysis. Clinical information was obtained from medical chart review. Immunohistochemical staining was performed for all of the tumor blocks. Staining was scored based on the intensity (intensity score 0–3) . Results Among the 20 cases of complex endometrial hyperplasia, 11 (55%) patients showed loss of expression of at least one of the following proteins: mutL homolog 1, mutS homolog 2, mutS homolog 6, or postmeiotic segregation increased 2. Seven (35%) patients were negative for the expression of two or more proteins, and one patient (5%) was negative for the expression of all four proteins. Conclusion More than half of the patients showed loss of expression of at least one mismatch repair protein in our study population. Genetic risk counseling and further tests are recommended for these patients.
Abstract
Objective Women with Lynch syndrome have an increased risk of developing colorectal and gynecologic malignancies such as endometrial cancer. Complex hyperplasia has about a 30% risk of developing into endometrial cancer. The aim of this study was to determine the genetic risk for developing endometrial cancer by immunohistochemical staining of premalignant lesions for mutL homolog 1, mutS homolog 2, mutS homolog 6, and postmeiotic segregation increased 2. Methods Twenty cases (n=20) were selected from among patients with available sample blocks for analysis. Clinical information was obtained from medical chart review. Immunohistochemical staining was performed for all of the tumor blocks. Staining was scored based on the intensity (intensity score 0–3) . Results Among the 20 cases of complex endometrial hyperplasia, 11 (55%) patients showed loss of expression of at least one of the following proteins: mutL homolog 1, mutS homolog 2, mutS homolog 6, or postmeiotic segregation increased 2. Seven (35%) patients were negative for the expression of two or more proteins, and one patient (5%) was negative for the expression of all four proteins. Conclusion More than half of the patients showed loss of expression of at least one mismatch repair protein in our study population. Genetic risk counseling and further tests are recommended for these patients.
참고문헌 (26)
- Siegel R., "Cancer statistics, 2013", CA Cancer J Clin, 63, pp.11~30 (2013)
- Emons G., "Hormonal interactions in endometrial cancer", Endocr Relat Cancer, 7, pp.227~242 (2000)
- Sherman ME., "Theories of endometrial carcinogenesis : a multidisciplinary approach", Mod Pathol, 13, pp.295~308 (2000)
- Lacey JV Jr., "Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia", J Clin Oncol, 28, pp.788~792 (2010)
- Gruber SB., "A population-based study of endometrial cancer and familial risk in younger women. Cancer and Steroid Hormone Study Group", Cancer Epidemiol Biomarkers Prev, 5, pp.411~417 (1996)
- Meyer LA., "Endometrial cancer and Lynch syndrome : clinical and pathologic considerations", Cancer Control, 16, pp.14~22 (2009)
- Vasen HF., "New clinical criteria for hereditary nonpolyposis colorectal cancer(HNPCC, Lynch syndrome)proposed by the International Collaborative group on HNPCC", Gastroenterology, 116, pp.1453~1456 (1999)
- Fishel R., "The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer", Cell, 75, pp.1027~1038 (1993)
- Papadopoulos N., "Mutation of a mutL homolog in hereditary colon cancer", Science, 263, pp.1625~1629 (1994)
- Leach FS., "Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer", Cell, 75, pp.1215~1225 (1993)
- Bronner CE., "Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer", Nature, 368, pp.258~261 (1994)
- Burgart LJ., "Testing for defective DNA mismatch repair in colorectal carcinoma : a practical guide", Arch Pathol Lab Med, 129, pp.1385~1389 (2005)
- Hendriks YM., "Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma(Lynch syndrome)", Gastroenterology, 130, pp.312~322 (2006)
- Umar A., "Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer(Lynch syndrome)and microsatellite instability", J Natl Cancer Inst, 96, pp.261~268 (2004)
- Liu B., "Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients", Nat Med, 2, pp.169~174 (1996)
- Risinger JI., "Genetic instability of microsatellites in endometrial carcinoma", Cancer Res, 53, pp.5100~5103 (1993)
- Thibodeau SN., "Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes", Cancer Res, 56, pp.4836~4840 (1996)
- Dietmaier W., "Diagnostic microsatellite instability : definition and correlation with mismatch repair protein expression", Cancer Res, 57, pp.4749~4756 (1997)
- Leach FS., "Expression of the human mismatch repair gene hMSH2 in normal and neoplastic tissues", Cancer Res, 56, pp.235~240 (1996)
- Marcus VA., "Immunohistochemistry for hMLH1 and hMSH2 : a practical test for DNA mismatch repair-deficient tumors", Am J Surg Pathol, 23, pp.1248~1255 (1999)
- Tafe LJ., "Lynch syndrome presenting as endometrial cancer", Clin Chem, 60, pp.111~121 (2014)
- 정규원, "Prediction of Cancer Incidence and Mortality in Korea, 2013", Cancer Research and Treatment, 45(1), pp.15~21 (2013), 대한암학회
- Resnick KE., "Current and emerging trends in Lynch syndrome identification in women with endometrial cancer", Gynecol Oncol, 114, pp.128~134 (2009)
- Shia J., "Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry", J Mol Diagn, 10, pp.293~300 (2008)
- Schmeler KM., "Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome", N Engl J Med, 354, pp.261~269 (2006)
- Shia J., "Lynch syndrome-associated neoplasms : a discussion on histopathology and immunohistochemistry", Fam Cancer, 12, pp.241~260 (2013)